Short-term adaptation of postprandial lipoprotein secretion and intestinal gene expression to a high-fat diet

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 296, Issue 4, 2009, Pages

  Hernández Vallejo, Sandra Jimena ^a,b,c   Alqub, Malik ^a,b,c   Luquet, Serge ^c   Cruciani Guglielmacci, Céline ^c   Delerive, Philippe ^d   Lobaccaro, Jean Marc ^e   Kalopissis, Athina Despina ^a,b,c   Chambaz, Jean ^a,b,c   Rousset, Monique ^a,b,c   Lacorte, Jean Marc ^a,b,c  

^a SORBONNE UNIVERSITÉ   (France)

^b CENTRE DE RECHERCHE DES CORDELIERS   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d GLAXOSMITHKLINE   (France)

^e UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

Chylomicron; Enterocyte; Lipid metabolism; SREBP 1C

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; APOLIPOPROTEIN A4; APOLIPOPROTEIN B; CHYLOMICRON; LIPOPROTEIN; LIVER X RECEPTOR; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL; CELL RECEPTOR; DNA BINDING PROTEIN; SREBF1 PROTEIN, MOUSE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

ADAPTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BODY WEIGHT; CELL NUCLEUS; CONTROLLED STUDY; DIET RESTRICTION; FATTY ACID SYNTHESIS; GENE EXPRESSION; GENETIC TRANSCRIPTION; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTESTINE CELL; INTESTINE FUNCTION; LIPID DIET; LIPID METABOLISM; LIPOPROTEIN SECRETION; MALE; MOUSE; NONHUMAN; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN LOCALIZATION; SHORT COURSE THERAPY; WESTERN BLOTTING; ANIMAL; DRUG EFFECT; FAT INTAKE; GENE EXPRESSION REGULATION; GENETICS; INTESTINE; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; SECRETION; TIME; WEIGHT GAIN;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; DIETARY FATS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; INTESTINES; LIPOPROTEINS; MALE; MICE; MICE, KNOCKOUT; POSTPRANDIAL PERIOD; RECEPTORS, CYTOPLASMIC AND NUCLEAR; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TIME FACTORS; WEIGHT GAIN;

EID: 67149125396     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.90324.2008     Document Type: Article

References (41)

1. Ayala J, Bracy D, McGuinness O, Wasserman D. Considerations in the design of hyperinsulinemic-euglycemic clamps in the conscious mouse. Diabetes 55: 390-397, 2006.
2. Botham K, Avella M, Cantafora A, Bravo E. The lipolysis of chylomicrons derived from different dietary fats by lipoprotein lipase in vitro. Biochim Biophys Acta 1349: 257-263, 1997.
3. Cartwright I, Higgins J. Increased dietary triacylglycerol markedly enhances the ability of isolated rabbit enterocytes to secrete chylomicrons: an effect related to dietary fatty acid composition. J Lipid Res 40: 1858-1866, 1999.
4. Cummins C, Volle D, Zhang Y, McDonald J, Sion B, Lefrançois- Martinez A, Caira F, Veyssière G, Mangelsdorf D, Lobaccaro J. Liver X receptors regulate adrenal cholesterol balance. J Clin Invest 116: 1902-1912, 2006.
5. Duez H, Lamarche B, Uffelman K, Valero R, Cohn J, Lewis G. Hyperinsulinemia is associated with increased production rate of intestinal apolipoprotein B-48-containing lipoproteins in humans. Arterioscler Thromb Vasc Biol 26: 1357-1363, 2006.
6. Dugué-Pujol S, Rousset X, Pastier D, Quang N, Pautre V, Chambaz J, Chabert M, Kalopissis A. Human apolipoprotein A-II associates with triglyceride-rich lipoproteins in plasma and impairs their catabolism. J Lipid Res 47: 2631-2639, 2006.
7. Federico L, Naples M, Taylor D, Adeli K. Intestinal insulin resistance and aberrant production of apolipoprotein B48 lipoproteins in an animal model of insulin resistance and metabolic dyslipidemia: evidence for activation of protein tyrosine phosphatase-1B, extracellular signal-related kinase, and sterol regulatory element-binding protein-1c in the fructose-fed hamster intestine. Diabetes 55: 1316-1326, 2006.
8. Feedback on WHO/FAO global report on diet, nutrition, and non-communicable diseases. Public Health Nutr 6: 423-429, 2003.
9. Fukuda H, Noguchi T, Iritani N. Transcriptional regulation of fatty acid synthase gene and ATP citrate-lyase gene by Sp1 and Sp3 in rat hepatocytes(1). FEBS Lett 464: 113-117, 1999.
10. Gleeson A, Anderton K, Owens D, Bennett A, Collins P, Johnson A, White D, Tomkin G. The role of microsomal triglyceride transfer protein and dietary cholesterol in chylomicron production in diabetes. Diabetologia 42: 944-948, 1999.
11. Groot P, van Stiphout W, Krauss X, Jansen H, van Tol A, van Ramshorst E, Chin-On S, Hofman A, Cresswell S, Havekes L. Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler Thromb 11: 653-662, 1991.
12. Grønholdt M, Nordestgaard B, Nielsen T, Sillesen H. Echolucent carotid artery plaques are associated with elevated levels of fasting and postprandial triglyceride-rich lipoproteins. Stroke 27: 2166-2172, 1996.
13. Haidari M, Leung N, Mahbub F, Uffelman K, Kohen-Avramoglu R, Lewis G, Adeli K. Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance. Evidence that chronic fructose feeding in the hamster is accompanied by enhanced intestinal de novo lipogenesis and ApoB48-containing lipoprotein overproduction. J Biol Chem 277: 31646-31655, 2002.
14. Hegarty B, Bobard A, Hainault I, Ferré P, Bossard P, Foufelle F. Distinct roles of insulin and liver X receptor in the induction and cleavage of sterol regulatory element-binding protein-1c. Proc Natl Acad Sci USA 102: 791-796, 2005.
15. Himber J, Missano B, Rudling M, Hennes U, Kempen H. Effects of stigmastanyl-phosphocholine (Ro 16-6532) and lovastatin on lipid and lipoprotein levels and lipoprotein metabolism in the hamster on different diets. J Lipid Res 36: 1567-1585, 1995.
16. Hirokane H, Nakahara M, Tachibana S, Shimizu M, Sato R. Bile acid reduces the secretion of very low density lipoprotein by repressing microsomal triglyceride transfer protein gene expression mediated by hepatocyte nuclear factor-4. J Biol Chem 279: 45685-45692, 2004.
17. Hussain M. A proposed model for the assembly of chylomicrons. Atherosclerosis 148: 1-15, 2000.
18. Kalopissis A, Griglio S, Le Liepvre X. Intestinal very low density lipoprotein secretion in rats fed various amounts of fat. Biochim Biophys Acta 711: 33-39, 1982.
19. Karpe F, Steiner G, Uffelman K, Olivecrona T, Hamsten A. Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis 106: 83-97, 1994.
20. Kawano K, Qin S, Vieu C, Collet X, Jiang X. Role of hepatic lipase and scavenger receptor BI in clearing phospholipid/free cholesterol-rich lipoproteins in PLTP-deficient mice. Biochim Biophys Acta 1583: 133-140, 2002.
21. Kim J, Gimeno R, Higashimori T, Kim H, Choi H, Punreddy S, Mozell R, Tan G, Stricker-Krongrad A, Hirsch D, Fillmore J, Liu Z, Dong J, Cline G, Stahl A, Lodish H, Shulman G. Inactivation of fatty acid transport protein 1 prevents fat-induced insulin resistance in skeletal muscle. J Clin Invest 113: 756-763, 2004.
22. Latasa M, Griffin M, Moon Y, Kang C, Sul H. Occupancy and function of the -150 sterol regulatory element and -65 E-box in nutritional regulation of the fatty acid synthase gene in living animals. Mol Cell Biol 23: 5896-5907, 2003.
23. Lewis G, Uffelman K, Naples M, Szeto L, Haidari M, Adeli K. Intestinal lipoprotein overproduction, a newly recognized component of insulin resistance, is ameliorated by the insulin sensitizer rosiglitazone: studies in the fructose-fed Syrian golden hamster. Endocrinology 146: 247-255, 2005.
24. Mu H, Høy C. Intestinal absorption of specific structured triacylglycerols. J Lipid Res 42: 792-798, 2001.
25. Oliveros L, Videla A, Ramirez D, Gimenez M. Dietary fat saturation produces lipid modifications in peritoneal macrophages of mouse. J Nutr Biochem 14: 370-377, 2003.
26. Patsch J, Miesenböck G, Hopferwieser T, Mühlberger V, Knapp E, Dunn J, Gotto AJ, Patsch W. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb 12: 1336-1345, 1992.
27. Phillips C, Bennett A, Anderton K, Owens D, Collins P, White D, Tomkin G. Intestinal rather than hepatic microsomal triglyceride transfer protein as a cause of postprandial dyslipidemia in diabetes. Metabolism 51: 847-852, 2002.
28. Phillips C, Murugasu G, Owens D, Collins P, Johnson A, Tomkin G. Improved metabolic control reduces the number of postprandial apolipoprotein B-48-containing particles in type 2 diabetes. Atherosclerosis 148: 283-291, 2000.
29. Phillips M, Pullinger C, Kroes I, Kroes J, Hardman D, Chen G, Curtiss L, Gutierrez M, Kane J, Schumaker V. A single copy of apolipoprotein B-48 is present on the human chylomicron remnant. J Lipid Res 38: 1170-1177, 1997.
30. Pruneta V, Autran D, Ponsin G, Marcais C, Duvillard L, Verges B, Berthezene F, Moulin P. Ex vivo measurement of lipoprotein lipase-dependent very low density lipoprotein (VLDL)-triglyceride hydrolysis in human VLDL: an alternative to the postheparin assay of lipoprotein lipase activity? J Clin Endocrinol Metab 86: 797-803, 2001.
31. Redgrave T. Chylomicron metabolism. Biochem Soc Trans 32: 79-82, 2004.
32. Sato R, Miyamoto W, Inoue J, Terada T, Imanaka T, Maeda M. Sterol regulatory element-binding protein negatively regulates microsomal triglyceride transfer protein gene transcription. J Biol Chem 274: 24714-24720, 1999.
33. Stewart-Phillips J, Lough J, Skamene E. Genetically determined susceptibility and resistance to diet-induced atherosclerosis in inbred strains of mice. J Lab Clin Med 112: 36-42, 1988.
34. Taghibiglou C, Carpentier A, Van Iderstine S, Chen B, Rudy D, Aiton A, Lewis G, Adeli K. Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance. Evidence for enhanced lipoprotein assembly, reduced intracellular ApoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hamster model. J Biol Chem 275: 8416-8425, 2000.
35. Teran-Garcia M, Rufo C, Nakamura M, Osborne T, Clarke S. NF-Y involvement in the polyunsaturated fat inhibition of fatty acid synthase gene transcription. Biochem Biophys Res Commun 290: 1295-1299, 2002.
36. Tholstrup T, Ehnholm C, Jauhiainen M, Petersen M, Høy C, Lund P, Sandström B. Effects of medium-chain fatty acids and oleic acid on blood lipids, lipoproteins, glucose, insulin, and lipid transfer protein activities. Am J Clin Nutr 79: 564-569, 2004.
37. Tornvall P, Olivecrona G, Karpe F, Hamsten A, Olivecrona T. Lipoprotein lipase mass and activity in plasma and their increase after heparin are separate parameters with different relations to plasma lipoproteins. Arterioscler Thromb Vasc Biol 15: 1086-1093, 1995.
38. Van Heek M, Zilversmit D. Postprandial lipemia and lipoprotein lipase in the rabbit are modified by olive and coconut oil. Arteriosclerosis 10: 421-429, 1990.
39. Vidal R, Hernandez-Vallejo S, Pauquai T, Texier O, Rousset M, Chambaz J, Demignot S, Lacorte J. Apple procyanidins decrease cholesterol esterification and lipoprotein secretion in Caco-2/TC7 enterocytes. J Lipid Res 46: 258-268, 2005.
40. Weintraub M, Zechner R, Brown A, Eisenberg S, Breslow J. Dietary polyunsaturated fats of the W-6 and W-3 series reduce postprandial lipoprotein levels. Chronic and acute effects of fat saturation on postprandial lipoprotein metabolism. J Clin Invest 82: 1884-1893, 1988.
41. Xiang S, Cianflone K, Kalant D, Sniderman A. Differential binding of triglyceride-rich lipoproteins to lipoprotein lipase. J Lipid Res 40: 1655-1663, 1999.